Journal
MOLECULAR AND CELLULAR NEUROSCIENCE
Volume 92, Issue -, Pages 67-81Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.mcn.2018.06.005
Keywords
Alzheimer's disease; Cerebrovascular basement membrane; Microglia; BACE1; Antioxidants; Oxidative stress
Categories
Funding
- Instituto de Salud Carlos III [PI13/00907]
- Junta de Comunidades de Castilla La-Mancha [PPII-2014-010-P]
- Universidad de Castilla La-Mancha [GI20163390]
- Spanish Ministerio de Economia y Competitividad [SAF2016-79311-R]
Ask authors/readers for more resources
Structural and functional abnormalities in the cerebral microvasculature have been observed in Alzheimer's disease (AD) patients and animal models. One cause of hypoperfusion is the thickening of the cerebrovascular basement membrane (CVBM) due to increased collagen-IV deposition around capillaries. This study investigated whether these and other alterations in the cerebrovascular system associated with AD can be prevented by long-term dietary supplementation with the antioxidant ubiquinol (Ub) stabilized with Kaneka QH P30 powder containing ascorbic acid (ASC) in a mouse model of advanced AD (3 x Tg-AD mice, 12 months old). Animals were treated from prodromal stages of disease (3 months of age) with standard chow without or with Ub + ASC or ASC-containing vehicle and compared to wild-type (WT) mice. The number of beta-amyloid (AD) plaques in the hippocampus and entorhinal cortex was higher in female than in male 3 x Tg-AD mice. Extensive regions of hypoxia were characterized by a higher plaque burden in females only. This was abolished by Ub + ASC and, to a lesser extent, by ASC treatment. Irrespective of AD burden, increased collagen-IV deposition in the CVBM was observed in both male and female 3 x Tg-AD mice relative to WT animals; this was also abrogated in Ub + ASC- and ASC-treated mice. The chronic inflammation in the hippocampus and oxidative stress in peripheral leukocytes of 3 x Tg-AD mice were likewise reversed by antioxidant treatment. These results provide strong evidence that long-term antioxidant treatment can mitigate plasma oxidative stress, amyloid burden, and hypoxia in the AD brain parenchyma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available